Evaxion A/S

Hello, and welcome to the Evaction Business Update and third quarter 2025 financial results. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a telephone question, please press star 11 on your keypad to join the queue. To withdraw your question, press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand over to Birgitta Ronu, Interim CEO and CSO, Please go ahead.

Thank you.

Good morning and good afternoon, and thank you all for joining our Q3 2025 Business Update and Financial Resource Conference Call. I'm Birgitte Roeneck, Chief Scientific Officer and Interim CEO of Eviction. I'm joined today by Thomas Smith, Chief Financial Officer, and Mads Kronborg, Vice President of Investor Relations and Communications. I'll begin by walking through the agenda for today's presentation. I'll start with a brief introduction, followed by an R&D update, and then Thomas will present the Q3 financial results. And lastly, after a few conclusive remarks, we will open for questions. I'd like to remind everyone that today's presentation may contain forward-looking statements. and these are subjects to risk and uncertainties, and actual results may differ materially. First and foremost, I'm pleased to welcome Dr. Helen Taylor-Martin as the new CEO of Eviction, effective November 24th. So Dr. Taylor-Martin brings extensive biotech leadership, fundraising, and partnership experience Helen co-founded Adaptimmune and has held several senior executive roles in Adaptimmune. Helen holds a PhD in molecular immunology and an MBA. And with more than 30 years of experience in early research through project approval, Helen is an ideal candidate to lead the next stages of election strategy. This also means that I will return to my previous role as CSO, and with Helen's transition from director in the board to CEO, Jens Bitsch-Nørhe will join the board as an advisor and observer with the intention to seek election at the next AGM.